Medically monitored care
Dr. Nitish Mandal provides medically monitored ketamine infusion therapy in Bangalore at his Koramangala and J.P. Nagar pain clinics, for selected patients with difficult-to-treat chronic pain and treatment-resistant depression. A first visit is required before an infusion is recommended.
Depression
Widespread pain
Emotional trauma
Nerve pain
Dr. Nitish Mandal, Consultant Pain Physician, provides medically monitored ketamine infusion therapy in Bangalore. Infusions may be considered for selected patients at Koramangala Pain Clinic and J.P. Nagar Pain Clinic.
This page describes one treatment that may be considered after diagnosis. Care starts with the source of the pain, or with a separate assessment when the question is treatment-resistant depression. Ketamine is not presented as a service you simply book.
Ketamine infusion therapy at this clinic is a medically monitored, low-dose IV session of about one hour. Low-dose ketamine is mixed with saline and given slowly through a cannula in the arm, with the doctor present throughout.
It may be considered for selected patients with severe, persistent, refractory chronic pain, including fibromyalgia, neuropathic pain, and Complex Regional Pain Syndrome (CRPS). Treatment-resistant depression is assessed on a separate pathway.
The clinics use specialised protocols in a medically monitored setting. Suitability is confirmed in clinic, not from a webpage.
Ketamine infusion may be considered for selected patients whose chronic pain or treatment-resistant depression has not responded adequately to conventional treatment.
This is not a first-line treatment for every person with fibromyalgia, nerve pain, CRPS, or depression. It is a selected option for difficult-to-treat cases after assessment.
The decision depends on:
A consultation is required before an infusion is recommended. The first visit is to understand the pattern of pain or mood symptoms, then decide whether an infusion belongs in the plan.
Chronic pain conditions such as fibromyalgia, CRPS, and severe neuropathic pain can be debilitating. Standard tablets and other treatments often fail to give enough relief.
Ketamine may be considered in selected patients with these conditions, particularly when pain is severe, persistent, and refractory to other treatments.
The evidence is not equally strong for every condition. It is generally stronger in some refractory neuropathic pain and CRPS settings. Evidence for fibromyalgia remains more limited or mixed. That is why the fibromyalgia page lists ketamine as one option for selected, difficult cases after the pattern of pain and sleep is understood, not as the opening of the visit.
Low-dose IV ketamine is thought to act mainly as an NMDA-receptor antagonist. In pain care, that mechanism is discussed as a way to reduce central sensitisation and abnormal pain transmission. It is not described here as resetting the brain or resetting pain receptors.
Whether an infusion belongs in the plan is confirmed in clinic.
Treatment-resistant depression is a separate pathway from chronic-pain care. Ketamine may be discussed for selected people who have not responded adequately to standard antidepressants. It may also be discussed when depression is severe and has not responded to usual care. It is not a first-line depression treatment, and it is not a cure.
Ketamine is described as acting on NMDA receptors in the brain. IV ketamine and intranasal esketamine (Spravato) are related medicines, but they are not the same treatment.
This clinic setting is not a replacement for emergency psychiatric care. If you have active suicidal thoughts, feel you may act on them, or are in immediate danger, seek urgent emergency or psychiatric care rather than waiting for a ketamine consultation.
Ketamine infusion therapy may be considered in selected, difficult-to-treat cases. It is not presented as a standard treatment for every person with these labels.
Separate assessment pathway
No. Ketamine and esketamine are related medicines but are not the same treatment.
Esketamine is a specific ketamine-derived medication with approved psychiatric indications in some countries, and in those settings it has a restricted administration and monitoring framework. IV ketamine itself is not the same product, and it may be used off-label in selected clinical situations after medical assessment.
This page is about medically monitored IV ketamine infusion therapy in Bangalore. It is not a guide to esketamine prescribing, and it does not treat the two as interchangeable.
Ketamine is given here only as a medically supervised clinic infusion. A low dose and a slow infusion do not mean the treatment is risk-free. Monitoring matters because important effects can occur during and after the session.
These effects are why the doctor monitors the session, why the setting is not the same as recreational use, and why going home is decided after the infusion, not in advance. Ketamine also has recognised misuse and dependence potential. That is another reason it is not given as an unsupervised or walk-in treatment.
No. The clinic uses a low dose, given as a slow medical infusion, with continuous monitoring by the doctor. That setting is not the same as recreational use.
Ketamine has misuse and dependence potential, which is why treatment should be prescribed and administered under medical supervision. Repeated medically indicated infusions are not, by themselves, evidence of addiction. Before further sessions are recommended, the patient's response, risks, medical history, and ongoing clinical need are reassessed.
Some people need further sessions. The need is reviewed as recovery continues. Further treatment is a clinical decision, not a standing booking.
An infusion generally lasts approximately one hour. Time in clinic can be longer than the infusion itself because of preparation and monitoring afterwards. Some patients may require more than one session. The number and spacing of infusions depend on the diagnosis, response, medical history, risks and treatment plan, and are reassessed as treatment continues. Going home the same day is common, but it is decided after the session, not from this page.
The cost of ketamine infusion therapy depends on the clinical plan and requirements. The current consultation and treatment charges are confirmed by the clinic before treatment.
Dr. Nitish Mandal provides medically monitored ketamine infusions at two Bangalore (Bengaluru) pain clinics. Prior appointment is preferred.
Sulochana Building, 365, 1st Floor, 1st Cross Rd, 3rd Block, Koramangala, Bengaluru, Karnataka 560034. Near Santhosapuram 1st Cross Road. Convenient for Indiranagar, HSR Layout, and Central Bangalore.
Phone: +91 76249 97990
All days, 10 AM to 2 PM.
1st Floor, #15, Bannerghatta Rd, Sarakki Industrial Layout, 3rd Phase, J.P. Nagar, Bengaluru, Karnataka 560076. Above the MG showroom and below Cult Gym. Convenient for South Bangalore and Bannerghatta Road.
Phone: +91 99808 04636
Monday to Saturday, 4 PM to 6 PM.
WhatsApp: +91 80502 87888. Email: teamdrnitish@gmail.com.
Medically reviewed by Dr. Nitish Mandal, Consultant Pain Physician, Bangalore. MBBS, MD (Anaesthesiology), FIPM, TIPM (Nashville). Clinics: Koramangala Pain Clinic and J.P. Nagar Pain Clinic. Last reviewed: September 2026.
Page chat
The questions on this page, with answers taken from the same details shown above.
Chat
Pain clinic
Typically replies on WhatsApp
Is this a ketamine clinic?
No. Dr. Nitish Mandal is a Consultant Pain Physician in Bangalore. Ketamine infusion therapy may be considered for selected difficult-to-treat chronic pain, with a separate pathway for selected treatment-resistant depression.
Which conditions may be considered?
Selected, refractory cases of fibromyalgia, neuropathic pain, and CRPS, and selected treatment-resistant depression. Evidence is not equally strong for every condition. A first visit is required before an infusion is recommended.
How long is a session?
An infusion generally lasts approximately one hour, with the doctor monitoring throughout. Going home is decided after the session.
